1. Home
2. News
3. INTEG

INTEG - INTEG STOCK NEWS

IMPACT

SENTIMENT

11/13/2023 03:33 AM

INTEG : Nasdaq B : Nasdaq

Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data

clinical trial

IMPACT

SENTIMENT

11/10/2023 11:24 AM

INTEG : Nasdaq B : Nasdaq

Correction missing MAR reference: Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023

IMPACT

SENTIMENT

11/10/2023 02:47 AM

B : NYSE INTEG : Nasdaq

Clinical study of Integrum's OPRA™ Implant System on below-knee amputations will include up to 30 patients and is fully funded by the Department of Defense

clinical trial

IMPACT

SENTIMENT

11/09/2023 03:16 AM

B : NYSE INTEG : Nasdaq

Integrum publishes preliminary revenue, result and and cash flow figures for Q2, 2023

IMPACT

SENTIMENT

10/30/2023 04:01 AM

INTEG : Nasdaq B : Nasdaq

Integrum's OPRA™ Implant System gets FDA approval for clinical study on below-knee amputations

clinical trial fda approval

IMPACT

SENTIMENT

10/27/2023 08:02 AM

B : NYSE INTEG : Nasdaq

Integrum moves into Turkey

INTEG

Nasdaq:INTEG

INTEG Rankings

N/A Ranked by Market Cap

N/A Ranked by Stock Gains

N/A Ranked by Dividends

INTEG Stock Data